✦ LIBER ✦

Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma

✍ Scribed by Alessandro Re; Salvatore Casari; Chiara Cattaneo; Fabio Facchetti; GianPiero Cadeo; Giampiero Carosi; Giuseppe Rossi

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 89 KB
Volume: 92
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20011201)92:11<2739::aid-cncr10121>3.0.co;2-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy-related leukemia in patients wit

✍ Jed A. Katzel; Sanford J. Kempin; Portia Lagmay-Fuentes; William A. Cook; Freder 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB 👁 1 views

Prognostic factors after non-Hodgkin lym

Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus : Aquitaine cohort, France, 1986–1997

✍ Frantz Thiessard; Philippe Morlat; Catherine Marimoutou; Eric Labouyrie; Jean-Ma 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

## BACKGROUND. The prognosis for survival of patients infected with the human immunodeficiency virus (HIV) who develop non-Hodgkin lymphoma (NHL) usually is considered to be poor. To the authors' knowledge the impact of highly active antiretroviral therapy, recently introduced in HIV disease case m

Patterns of central nervous system recur

Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-Hodgkin lymphoma

✍ Jigna Desai; Robin J. Mitnick; David H. Henry; Josefina Llena; Joseph A. Sparano 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

BACKGROUND. Central nervous system involvement is a common manifestation of non-Hodgkin lymphoma (NHL) in human immunodeficiency virus (HIV)-infected individuals. The purpose of this study was to review the frequency and pattern of neurologic manifestation of lymphoma in a cohort of HIV-infected ind

Concomitant cyclophosphamide, doxorubici

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma

✍ Emanuela Vaccher; Michele Spina; Giampiero di Gennaro; Renato Talamini; Guglielm 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

Second-line chemotherapy in human immuno

Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: Evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients

✍ Umberto Tirelli; Domenico Errante; Michele Spina; Roberta Gastaldi; Ezio Nigra; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 1 views

## BACKGROUND. There is very little experience reported in the literature on the treatment of patients with relapsed or resistant human immunodeficiency virus-related non-Hodgkin's lymphoma (HIV-NIIL). We performed a prospective study to ovaluate the feasibility and activity of a second-line chemo